BSE Live
Dec 30, 16:01Prev. Close
1433.75
Open Price
1434.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 15:57Prev. Close
1434.60
Open Price
1440.00
Bid Price (Qty.)
1386.20 (1952)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Ipca Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 16.71 | 36.50 | 56.25 | 48.89 | 25.59 | |
| Diluted EPS (Rs.) | 16.71 | 36.50 | 56.25 | 48.89 | 25.59 | |
| Cash EPS (Rs.) | 20.51 | 52.34 | 69.08 | 60.56 | 35.58 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 69.88 | 255.51 | 242.19 | 194.41 | 154.36 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 69.88 | 255.51 | 242.19 | 194.41 | 154.36 | |
| Dividend / Share(Rs.) | 2.80 | 11.00 | 8.00 | 7.50 | 5.50 | |
| Revenue from Operations/Share (Rs.) | 128.44 | 528.04 | 446.66 | 380.32 | 312.16 | |
| PBDIT/Share (Rs.) | 27.56 | 77.74 | 90.75 | 80.17 | 46.51 | |
| PBIT/Share (Rs.) | 23.86 | 62.02 | 77.91 | 68.51 | 36.66 | |
| PBT/Share (Rs.) | 21.70 | 49.88 | 70.49 | 60.16 | 31.36 | |
| Net Profit/Share (Rs.) | 16.71 | 36.50 | 56.25 | 48.89 | 25.59 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 21.45 | 14.72 | 20.31 | 21.08 | 14.89 | |
| PBIT Margin (%) | 18.57 | 11.74 | 17.44 | 18.01 | 11.74 | |
| PBT Margin (%) | 16.89 | 9.44 | 15.78 | 15.81 | 10.04 | |
| Net Profit Margin (%) | 13.00 | 6.91 | 12.59 | 12.85 | 8.19 | |
| Return on Networth / Equity (%) | 23.91 | 14.28 | 23.22 | 25.14 | 16.57 | |
| Return on Capital Employed (%) | 17.76 | 9.72 | 16.63 | 18.48 | 14.64 | |
| Return on Assets (%) | 11.95 | 6.23 | 11.03 | 12.37 | 8.51 | |
| Total Debt/Equity (X) | 0.52 | 0.71 | 0.58 | 0.49 | 0.51 | |
| Asset Turnover Ratio (%) | 91.92 | 90.25 | 87.65 | 96.25 | 103.85 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.79 | 1.57 | 1.64 | 1.62 | 1.15 | |
| Quick Ratio (X) | 1.14 | 1.00 | 1.03 | 0.91 | 0.57 | |
| Inventory Turnover Ratio (X) | 4.34 | 4.40 | 4.32 | 4.09 | 4.26 | |
| Dividend Payout Ratio (NP) (%) | 16.73 | 30.24 | 14.20 | 15.33 | 21.49 | |
| Dividend Payout Ratio (CP) (%) | 13.63 | 21.09 | 11.56 | 12.38 | 15.45 | |
| Earnings Retention Ratio (%) | 83.27 | 69.76 | 85.80 | 84.67 | 78.51 | |
| Cash Earnings Retention Ratio (%) | 86.37 | 78.91 | 88.44 | 87.62 | 84.55 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,823.08 | 1,265.85 | 1,872.14 | 1,741.10 | 1,065.75 | |
| EV/Net Operating Revenue (X) | 2.38 | 0.96 | 1.67 | 1.83 | 1.37 | |
| EV/EBITDA (X) | 11.08 | 6.52 | 8.22 | 8.69 | 9.17 | |
| MarketCap/Net Operating Revenue (X) | 2.10 | 0.62 | 1.36 | 1.59 | 1.12 | |
| Retention Ratios (%) | 83.26 | 69.75 | 85.79 | 84.66 | 78.50 | |
| Price/BV (X) | 3.86 | 1.29 | 2.51 | 3.10 | 2.26 | |
| Price/Net Operating Revenue | 2.10 | 0.62 | 1.36 | 1.59 | 1.12 | |
| Earnings Yield | 0.06 | 0.11 | 0.09 | 0.08 | 0.07 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher